Cytokine profiles in COVID-19 patients undergoing adjunct ozone therapy: some comments.

Salvatore ChirumboloSergio PandolfiMarianno FranziniLuigi Valdenassi

Published in: Inflammopharmacology (2023)

A comment to: Ghaleh HEG, Izadi M, Javanbakht M, Ghanei M, Einollahi B, Jafari NJ, Alishiri G, Aslani J, Abolghasemi H, Simonetti V, Khafaei M, Zhao S, Saadat SH, Ahmadi M, Parvin S, Vazifedoust S, Alvanagh AG. Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement. Inflammopharmacology. 2023 Jul 12. https://doi.org/10.1007/s10787 -023-01288-9.

Keyphrases

sars cov
patients undergoing
coronavirus disease
hydrogen peroxide
particulate matter
study protocol
early onset
high intensity
nitric oxide
mesenchymal stem cells
drug induced
cell therapy
open label
drug discovery